New Delhi, Dec 11: Russian Direct Investment Fund (RDIF) on Friday said pharma firm AstraZeneca has accepted its offer to use one of the two components of the Sputnik V vaccine in the latter''s clinical trials. RDIF and Gamaleya
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/3aenAoH
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/3aenAoH
ConversionConversion EmoticonEmoticon